Corbus Pharmaceuticals Holdings, Inc. (31)

Browse by Contract Category

Contracts

Amendment to Loan Agreement (Filed With SEC on October 31, 2022)
Form of Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Craig Millian (Filed With SEC on April 15, 2022)
License Agreement, dated May 26, 2021, between Corbus Pharmaceuticals, Inc. and The Regents of the University of California (Filed With SEC on August 12, 2021)
Open Market Sale AgreementSM, dated August 6, 2020, by and between the Registrant and Jefferies LLC (Filed With SEC on August 6, 2020)
Lease Amendment No. 2 dated as of October 25, 2019, among River Ridge Limited Partnership, Corbus Pharmaceuticals, Inc. and Corbus Pharmaceuticals Holdings, Inc (Filed With SEC on November 7, 2019)
Collaboration and License Agreement, dated January 3, 2019, between Corbus Pharmaceuticals, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on January 3, 2019)
Form of Fifth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran (Filed With SEC on April 15, 2022)
Form of Fourth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen (Filed With SEC on April 15, 2022)
Employment Agreement between the Company and Rachael Brake, effective as of December 6, 2021 (Filed With SEC on March 8, 2022)
Description of Capital Stock (Filed With SEC on March 8, 2022)
Amendment to Employment Agreement between Corbus Pharmaceuticals Holdings, Inc., and Craig Millian, effective as of September 27, 2021 (Filed With SEC on September 28, 2021)
Separation and General Release Agreement between the Company and Barbara White, dated September 17, 2021 (Filed With SEC on September 22, 2021)
License Agreement, dated May 25, 2021, between Corbus Pharmaceuticals, Inc. and Milky Way BioPharma, LLC (Filed With SEC on August 12, 2021)
Separation and Release Agreement between the Company and Robert Discordia, dated November 30, 2020 (Filed With SEC on December 4, 2020)
Form of Warrant to Purchase Common Stock (Filed With SEC on July 29, 2020)
Loan and Security Agreement, dated as of July 28, 2020, by and between Corbus Pharmaceuticals Holdings, Inc., Corbus Pharmaceuticals, Inc., K2 Healthventures LLC and Ankura Trust... (Filed With SEC on July 29, 2020)
Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Craig Millian, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)
Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Robert Discordia, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)
Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Barbara White, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)
Fourth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)
Third Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)
Form of Third Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran (Filed With SEC on April 1, 2020)
Form of Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Barbara White (Filed With SEC on April 1, 2020)
Form of Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen (Filed With SEC on April 1, 2020)
Description of Capital Stock (Filed With SEC on March 16, 2020)
Underwriting Agreement, dated February 7, 2020 (Filed With SEC on February 7, 2020)
Consulting Agreement between Corbus Pharmaceutical Holdings, Inc. and Mark Tepper, dated March 31, 2019 (Filed With SEC on April 1, 2019)
Separation Agreement between Corbus Pharmaceutical Holdings, Inc. and Mark Tepper, dated March 31, 2019 (Filed With SEC on April 1, 2019)
Offer Letter, dated as of February 19, 2019, between Craig Millian and Corbus Pharmaceuticals, Inc (Filed With SEC on March 12, 2019)
Lease Amendment No. 1, dated as of February 26, 2019, among River Ridge Limited Partnership, Corbus Pharmaceuticals, Inc. and Corbus Pharmaceuticals Holdings, Inc (Filed With SEC on March 12, 2019)
Underwriting Agreement, dated January 25, 2019 (Filed With SEC on January 25, 2019)